Developer docs
API playgroundTry for free, no card

Search company profiles

Dermadry

Full company profile

uuid000ns7l

Namestring
Dermadry
Legal namestring
Dermadry Laboratories Inc.
Websiteurl
dermadry.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Dermadry Laboratories Inc. is a privately held Canadian medical device company headquartered in Montréal that designs, manufactures, and sells tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms. The company's core product line consists of three devices — Dermadry Total, Dermadry Hands & Feet, and Dermadry Underarms — each delivering pulsed electrical current (1–15 mA for hands and feet, 1–8 mA for underarms) through water to temporarily disrupt sweat gland signaling. Notable technical components include aluminum-free graphite silicone electrodes, preset treatment profiles with polarity alternating sequences, and a safety pause function that prevents electric shock. The devices are assembled in Canada under ISO 13485:2016 MDSAP quality management procedures.

Dermadry operates a direct-to-consumer e-commerce model through dermadry.com, supplemented by Amazon marketplace listings and an authorized distributor in India (Jolly Technocrats). Pricing is structured as one-time device purchases ranging from $292.50 to $500, with recurring consumable revenue from replacement electrodes, underarm pockets, and silicone mats recommended for replacement every 30 sessions. Interest-free installment plans via Splitit (3–12 months) and HSA/FSA eligibility in the US reduce affordability friction. The primary customer segment is individuals aged 13+ (21+ in the US) with primary hyperhidrosis, supported by a secondary referral channel of dermatologists, podiatrists, and physicians.

The company has secured a multi-jurisdiction regulatory footprint, including Health Canada Medical Device Licence No. 101550 (2018), FDA 510(k) clearance K192749 (February 2020), CE marking via TÜV-SÜD, Australian Register of Therapeutic Goods registration, and ISO 13485 MDSAP certification. Distribution extends to more than 100 countries with free express shipping. Dermadry is founder-owned with no disclosed external institutional investment, no parent company, and no subsidiaries.

Short descriptiontext

Dermadry is a Canadian medical device company that designs and sells FDA-cleared tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms, sold direct-to-consumer globally across 100+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMontréal, Canada
HQ citystring
Montréal
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
iontophoresis devices, hyperhidrosis treatment, medical devices, excessive sweating, at-home treatment
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Devices for Hyperhidrosis
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Iontophoresis Device Sales
TypeOne Time License
Description

One-time purchase of medical devices (Dermadry Total, Hands & Feet, Underarms) providing long-term treatment solution. Prices range from $292.50-$500 with free express shipping worldwide.

dermadry.com
2Consumables and Accessories
TypeHardware Sales
Description

Replacement consumables including underarm pockets ($12.35-$19), silicone electrodes ($38.35-$51.35), silicone mats ($25.35-$39), and electrode bundles. Regular replacement recommended every 30 sessions.

dermadry.com
3Payment Plan Financing
TypeTransaction Fee
Description

Interest-free installment payments through Splitit partnership, allowing customers to pay over 3-12 months. Revenue received upfront from Splitit.

dermadry.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D
Pricing details5 tiers
1Dermadry Total - Complete package for hands, feet & underarms
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$500 regular price, currently $325 (35% Cyber Monday discount). Also available for $25/month via Splitit payment plan.

dermadry.com
2Dermadry Hands & Feet - For palmar and plantar hyperhidrosis
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$475 regular price, currently $308.75 (35% Cyber Monday discount). Also available for $23/month via Splitit.

dermadry.com
3Dermadry Underarms - Targeted axillary treatment
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$450 regular price, currently $292.50 (35% Cyber Monday discount). Also available for $22/month via Splitit.

dermadry.com
4Upgrade Kit - For existing Dermadry Total users
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$199 regular price, currently $129.35 (35% Cyber Monday discount). Includes upgraded electrodes, mats, and compact case.

dermadry.com
5Consumables (pockets, electrodes, mats)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Underarm Pockets: $12.35 (sale from $19), Underarm Silicone-Graphite Electrodes: $38.35 (sale from $59), Hands & Feet Silicone-Graphite Electrodes: $51.35 (sale from $79), Silicone Mats: $25.35 (sale from $39).

dermadry.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Dermadry manufactures and sells tap water iontophoresis medical devices for the at-home treatment of hyperhidrosis (excessive sweating) affecting hands, feet, and underarms. The company offers three core devices (Dermadry Total, Dermadry Hands & Feet, Dermadry Underarms) along with replacement consumables such as silicone-graphite electrodes, underarm pockets, and silicone mats. The devices use mild pulsed electrical current transmitted through tap water to temporarily halt sweat gland activity, providing drug-free, non-invasive relief lasting up to 6 weeks with maintenance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 98.3% of users experience reduction in sweat levels (749-person internal survey)
+4 more records
Product overview1 text field

Dermadry offers a portfolio of iontophoresis medical devices for treating hyperhidrosis (excessive sweating). The core product line consists of three main devices: Dermadry Total (treats hands, feet, and underarms), Dermadry Hands & Feet (treats palmar and plantar hyperhidrosis), and Dermadry Underarms (treats axillary hyperhidrosis). The product portfolio also includes an Upgrade Kit with silicone-graphite electrodes and silicone mats for newer models, along with various consumables including underarm pockets, replacement electrodes, and silicone mats. The devices use tap water iontophoresis technology—a non-invasive, drug-free treatment that uses mild electrical current to temporarily block sweat gland production, providing results lasting up to 6 weeks with maintenance treatments.

Product and service9 records
1Dermadry Total
CategoryIontophoresis medical device
Description

Complete iontophoresis machine for treating hyperhidrosis affecting hands, feet, and underarms. FDA-cleared and Health Canada-licensed for palmar, plantar, and axillary hyperhidrosis, providing up to 6 weeks of dryness between maintenance treatments.

2Dermadry Hands & Feet
CategoryIontophoresis medical device
Description

Iontophoresis device designed for treating excessive sweating of the hands and feet (palmar and plantar hyperhidrosis). Includes treatment trays, electrodes, silicone mats, controller, and compact carrying case.

3Dermadry Underarms
CategoryIontophoresis medical device
Description

Iontophoresis machine specifically designed for treating excessive underarm sweating (axillary hyperhidrosis). Features 15-minute treatment sessions with 1-8 mA current strength.

4Dermadry Upgrade Kit
CategoryDevice accessory bundle
Description

Standalone upgrade kit for existing Dermadry Total device owners, providing aluminum-free and latex-free silicone-graphite electrodes, perforated silicone mats, and a compact carrying case to modernize older units.

5Set of Underarms Pockets
CategoryConsumable accessory
Description

Replacement underarm pockets made from absorbent material designed to absorb the right amount of water for comfortable iontophoresis treatment of axillary hyperhidrosis.

6Hands & Feet Silicone-Graphite Electrodes
CategoryConsumable accessory
Description

Replacement conductive graphite silicone electrodes providing an aluminum-free treatment option for hands and feet iontophoresis. Flexible, tear-resistant, corrosion-resistant, and durable construction.

7Underarm Silicone-Graphite Electrodes
CategoryConsumable accessory
Description

Replacement underarm silicone-graphite electrodes designed to embrace the underarm for safe and localized iontophoresis treatment. Aluminum-free construction suitable for users with aluminum sensitivities.

8Set of Silicone Mats
CategoryConsumable accessory
Description

Easy-to-clean silicone mats for protecting hands and feet during iontophoresis treatment. Waterproof and replace traditional cotton towels for quick post-treatment clean-up.

9Consumable Bundle - Underarms
CategoryConsumable accessory bundle
Description

Complete underarm treatment bundle including underarm electrodes along with two sets of underarm pockets, designed for users of older Dermadry underarm devices.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1Jolly Technocrats
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor in India enabling customers to purchase Dermadry products locally. Addresses customs concerns that prevent direct international shipping to India. Contact via jollytechnocrats.in.

dermadry.com
2Splitit
Strategic tierCoreTypeGTM or Marketing Partner
Description

Payment plan provider enabling interest-free installments (3-12 months) for Dermadry purchases. No credit check, instant approval. Works with existing credit cards. Enables higher ticket purchases.

dermadry.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Non-profit organization supporter. Dermadry featured on IHHS website as recommended treatment option. Supports hyperhidrosis awareness initiatives including Voices of Hyperhidrosis campaign.

4Board-Certified Dermatologists (Dr. Ramin Fathi, Dr. Raj Singh, Dr. Ryan De Cruz)
Strategic tierMinorTypeGTM or Marketing Partner
Description

Medical professionals who recommend Dermadry to patients and provide testimonials/endorsements. Quotes featured on website as trust signals for customer acquisition.

dermadry.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers7 records
TypeDirect peer
Description

Established US iontophoresis device manufacturer serving medical and physical therapy markets, including hyperhidrosis treatment. Closely comparable in product category, customer base (patients + clinicians), and regulated medical-device positioning.

TypeEmerging player
Description

DTC antiperspirant brand specifically formulated for hyperhidrosis, with strong social-media presence and target-customer overlap. Competes for the same hyperhidrosis consumer dollar but via topical OTC rather than device-based treatment.

TypeBroad incumbent
Description

Owns Botox, an FDA-approved neurotoxin injection for severe primary axillary hyperhidrosis. Competes indirectly for the same patient population via a clinical in-office procedure, and frequently cited as Dermadry's main alternative-treatment option.

TypeEmerging player
Description

Developer of the miraDry system, a microwave-based in-office procedure for axillary hyperhidrosis. Comparable only in target condition (hyperhidrosis) but uses an entirely different treatment modality and delivery setting (clinical vs. at-home).

5Botanix Pharmaceuticals
TypeEmerging player
Description

Developer of sofpironium bromide (Sofdra), a topical prescription gel for primary axillary hyperhidrosis. Adjacent modality (topical) sharing the same target condition; potential direct competitor for at-home hyperhidrosis treatment.

TypeDirect peer
Description

German manufacturer of iontophoresis devices for hyperhidrosis, with a long-standing presence in Europe and a US arm. Direct competitor in the same product modality (tap-water iontophoresis) targeting the same hyperhidrosis patient base.

TypeDirect peer
Description

UK-based company that historically supplied iontophoresis devices (Iontophor) and related dermatology products for hyperhidrosis. Direct competitor in iontophoresis modality with comparable DTC and clinical channels.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dermadry

Medical Devices for Hyperhidrosisdermadry.com

Dermadry is a Canadian medical device company that designs and sells FDA-cleared tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms, sold direct-to-consumer globally across 100+ countries.

What Dermadry does

Dermadry Laboratories Inc. is a privately held Canadian medical device company headquartered in Montréal that designs, manufactures, and sells tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms. The company's core product line consists of three devices — Dermadry Total, Dermadry Hands & Feet, and Dermadry Underarms — each delivering pulsed electrical current (1–15 mA for hands and feet, 1–8 mA for underarms) through water to temporarily disrupt sweat gland signaling. Notable technical components include aluminum-free graphite silicone electrodes, preset treatment profiles with polarity alternating sequences, and a safety pause function that prevents electric shock. The devices are assembled in Canada under ISO 13485:2016 MDSAP quality management procedures.

Dermadry operates a direct-to-consumer e-commerce model through dermadry.com, supplemented by Amazon marketplace listings and an authorized distributor in India (Jolly Technocrats). Pricing is structured as one-time device purchases ranging from $292.50 to $500, with recurring consumable revenue from replacement electrodes, underarm pockets, and silicone mats recommended for replacement every 30 sessions. Interest-free installment plans via Splitit (3–12 months) and HSA/FSA eligibility in the US reduce affordability friction. The primary customer segment is individuals aged 13+ (21+ in the US) with primary hyperhidrosis, supported by a secondary referral channel of dermatologists, podiatrists, and physicians.

The company has secured a multi-jurisdiction regulatory footprint, including Health Canada Medical Device Licence No. 101550 (2018), FDA 510(k) clearance K192749 (February 2020), CE marking via TÜV-SÜD, Australian Register of Therapeutic Goods registration, and ISO 13485 MDSAP certification. Distribution extends to more than 100 countries with free express shipping. Dermadry is founder-owned with no disclosed external institutional investment, no parent company, and no subsidiaries.

Dermadry firmographics

Firmographics
Name
Dermadry
Legal name
Dermadry Laboratories Inc.
Website
https://dermadry.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Dermadry is a Canadian medical device company that designs and sells FDA-cleared tap water iontophoresis devices for the at-home treatment of hyperhidrosis (excessive sweating) of the hands, feet, and underarms, sold direct-to-consumer globally across 100+ countries.
Ownership category
akta.pro rank

Where Dermadry is headquartered

Location

Headquarters

HQ city
Montréal
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Dermadry business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Personnel, Operations, Technology or R&D

Revenue model

  1. Iontophoresis Device Sales: One-time purchase of medical devices (Dermadry Total, Hands & Feet, Underarms) providing long-term treatment solution. Prices range from $292.50-$500 with free express shipping worldwide.
  2. Consumables and Accessories: Replacement consumables including underarm pockets ($12.35-$19), silicone electrodes ($38.35-$51.35), silicone mats ($25.35-$39), and electrode bundles. Regular replacement recommended every 30 sessions.
  3. Payment Plan Financing: Interest-free installment payments through Splitit partnership, allowing customers to pay over 3-12 months. Revenue received upfront from Splitit.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goDermadry Total - Complete package for hands, feet & underarms
One time/ perpetual licensePay-as-you-goDermadry Hands & Feet - For palmar and plantar hyperhidrosis
One time/ perpetual licensePay-as-you-goDermadry Underarms - Targeted axillary treatment
One time/ perpetual licensePay-as-you-goUpgrade Kit - For existing Dermadry Total users
Unit PricingPay-as-you-goConsumables (pockets, electrodes, mats)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Dermadry product offering

Product offering

Core offering

Dermadry manufactures and sells tap water iontophoresis medical devices for the at-home treatment of hyperhidrosis (excessive sweating) affecting hands, feet, and underarms. The company offers three core devices (Dermadry Total, Dermadry Hands & Feet, Dermadry Underarms) along with replacement consumables such as silicone-graphite electrodes, underarm pockets, and silicone mats. The devices use mild pulsed electrical current transmitted through tap water to temporarily halt sweat gland activity, providing drug-free, non-invasive relief lasting up to 6 weeks with maintenance.

Product overview

Dermadry offers a portfolio of iontophoresis medical devices for treating hyperhidrosis (excessive sweating). The core product line consists of three main devices: Dermadry Total (treats hands, feet, and underarms), Dermadry Hands & Feet (treats palmar and plantar hyperhidrosis), and Dermadry Underarms (treats axillary hyperhidrosis). The product portfolio also includes an Upgrade Kit with silicone-graphite electrodes and silicone mats for newer models, along with various consumables including underarm pockets, replacement electrodes, and silicone mats. The devices use tap water iontophoresis technology—a non-invasive, drug-free treatment that uses mild electrical current to temporarily block sweat gland production, providing results lasting up to 6 weeks with maintenance treatments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dermadry Total Complete iontophoresis machine for treating hyperhidrosis affecting hands, feet, and underarms. FDA-cleared and Health Canada-licensed for palmar, plantar, and axillary hyperhidrosis, providing up to 6 weeks of dryness between maintenance treatments.
  • Dermadry Hands & Feet Iontophoresis device designed for treating excessive sweating of the hands and feet (palmar and plantar hyperhidrosis). Includes treatment trays, electrodes, silicone mats, controller, and compact carrying case.
  • Dermadry Underarms Iontophoresis machine specifically designed for treating excessive underarm sweating (axillary hyperhidrosis). Features 15-minute treatment sessions with 1-8 mA current strength.
  • Dermadry Upgrade Kit Standalone upgrade kit for existing Dermadry Total device owners, providing aluminum-free and latex-free silicone-graphite electrodes, perforated silicone mats, and a compact carrying case to modernize older units.
  • Set of Underarms Pockets Replacement underarm pockets made from absorbent material designed to absorb the right amount of water for comfortable iontophoresis treatment of axillary hyperhidrosis.
  • Hands & Feet Silicone-Graphite Electrodes Replacement conductive graphite silicone electrodes providing an aluminum-free treatment option for hands and feet iontophoresis. Flexible, tear-resistant, corrosion-resistant, and durable construction.
  • Underarm Silicone-Graphite Electrodes Replacement underarm silicone-graphite electrodes designed to embrace the underarm for safe and localized iontophoresis treatment. Aluminum-free construction suitable for users with aluminum sensitivities.
  • Set of Silicone Mats Easy-to-clean silicone mats for protecting hands and feet during iontophoresis treatment. Waterproof and replace traditional cotton towels for quick post-treatment clean-up.
  • Consumable Bundle - Underarms Complete underarm treatment bundle including underarm electrodes along with two sets of underarm pockets, designed for users of older Dermadry underarm devices.

Quantifiable outcome

  • 98.3% of users experience reduction in sweat levels (749-person internal survey)
  • +4 more outcomes

Companies that use Dermadry

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Dermadry technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Dermadry partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered regional, core and minor.

  • Jolly TechnocratsregionalChannel Partner/ Reseller/ DistributorAuthorized distributor in India enabling customers to purchase Dermadry products locally. Addresses customs concerns that prevent direct international shipping to India. Contact via jollytechnocrats.in.
  • SplititcoreGTM or Marketing PartnerPayment plan provider enabling interest-free installments (3-12 months) for Dermadry purchases. No credit check, instant approval. Works with existing credit cards. Enables higher ticket purchases.
  • International Hyperhidrosis SocietyminorStrategic or Co-development PartnerNon-profit organization supporter. Dermadry featured on IHHS website as recommended treatment option. Supports hyperhidrosis awareness initiatives including Voices of Hyperhidrosis campaign.
  • Board-Certified Dermatologists (Dr. Ramin Fathi, Dr. Raj Singh, Dr. Ryan De Cruz)minorGTM or Marketing PartnerMedical professionals who recommend Dermadry to patients and provide testimonials/endorsements. Quotes featured on website as trust signals for customer acquisition.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Dermadry competitors and assessment

Company assessment

Direct peers

  • R.A. Fischer: Established US iontophoresis device manufacturer serving medical and physical therapy markets, including hyperhidrosis treatment. Closely comparable in product category, customer base (patients + clinicians), and regulated medical-device positioning.
  • Hidrex: German manufacturer of iontophoresis devices for hyperhidrosis, with a long-standing presence in Europe and a US arm. Direct competitor in the same product modality (tap-water iontophoresis) targeting the same hyperhidrosis patient base.
  • STD Pharmaceutical Products: UK-based company that historically supplied iontophoresis devices (Iontophor) and related dermatology products for hyperhidrosis. Direct competitor in iontophoresis modality with comparable DTC and clinical channels.

Emerging players

  • Carpe: DTC antiperspirant brand specifically formulated for hyperhidrosis, with strong social-media presence and target-customer overlap. Competes for the same hyperhidrosis consumer dollar but via topical OTC rather than device-based treatment.
  • Miramar Labs (miraDry): Developer of the miraDry system, a microwave-based in-office procedure for axillary hyperhidrosis. Comparable only in target condition (hyperhidrosis) but uses an entirely different treatment modality and delivery setting (clinical vs. at-home).
  • Botanix Pharmaceuticals: Developer of sofpironium bromide (Sofdra), a topical prescription gel for primary axillary hyperhidrosis. Adjacent modality (topical) sharing the same target condition; potential direct competitor for at-home hyperhidrosis treatment.

Broad incumbents

  • AbbVie (Botox): Owns Botox, an FDA-approved neurotoxin injection for severe primary axillary hyperhidrosis. Competes indirectly for the same patient population via a clinical in-office procedure, and frequently cited as Dermadry's main alternative-treatment option.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Dermadry social profiles

Digital presence

Dermadry compliance and trust

Trust signal

Compliance7 records

Dermadry financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dermadry leadership team

Management profile

Number of profiles

Dermadry funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dermadry M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dermadry

What does Dermadry do?

Dermadry manufactures and sells tap water iontophoresis medical devices for the at-home treatment of hyperhidrosis (excessive sweating) affecting hands, feet, and underarms. The company offers three core devices (Dermadry Total, Dermadry Hands & Feet, Dermadry Underarms) along with replacement consumables such as silicone-graphite electrodes, underarm pockets, and silicone mats. The devices use mild pulsed electrical current transmitted through tap water to temporarily halt sweat gland activity, providing drug-free, non-invasive relief lasting up to 6 weeks with maintenance.

Is Dermadry a public or private company?

Dermadry is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dermadry founded?

Dermadry was founded in 2018. It employs 11 to 50 people.

Where is Dermadry based?

Dermadry is headquartered in Montréal, Canada, in the North America region.

How does Dermadry make money?

Three revenue lines are on record. Iontophoresis Device Sales are the primary driver. The others are consumables and Accessories and payment Plan Financing.

Who are Dermadry's main competitors?

Direct peers on record are R.A. Fischer, Hidrex and STD Pharmaceutical Products. Emerging players are Carpe, Miramar Labs (miraDry) and Botanix Pharmaceuticals. AbbVie (Botox) is listed as a broad incumbent.

Does Dermadry have an API?

No public API is recorded for Dermadry.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewswireDermadry Partners With Today's Shopping ChoiceDermadry, a Canadian medical device company, has made its iontophoresis machines for hyperhidrosis available on TSC. The collaboration includes a 15% discount from June 18 to July 4. The company estimates about 5% of Canadians suffer from the condition.PR NewswireAre You a Student Who Sweats a Lot? Apply for Dermadry's $2,000 ScholarshipDermadry, a Canadian medical device company headquartered in Montreal, has launched its Hyperhidrosis Scholarship for students with excessive sweating, with submissions open from August 5 to August 22, 2021. The prize includes a US$2,000 scholarship and a Dermadry Total iontophoresis device valued at US$499, with ten finalists to be selected by the Dermadry team and an additional four spots reserved for entries with the greatest social media reach. The scholarship is open globally to students enrolled in post-secondary educational institutions, with public voting determining the winner.PR NewswireDermadry Secures Regulatory Certification in European MarketsDermadry, a Montreal-based medical device company specializing in treatments for hyperhidrosis (excessive sweating), has obtained CE Marking certification for its Iontophoresis device, enabling commercial deployment across European markets. The company previously received regulatory approvals from Health Canada, the FDA, and Australia's Department of Health, and can now commercialize its products in North America, Europe, and Australia. Dermadry stated the certification brings it closer to international expansion and diversifying revenue across multiple markets.PR NewswireDermadry's Santa Claus is Coming to Town for the 2020 Holiday SeasonDermadry, a Canadian medical device company headquartered in Montreal, has launched its second annual 'Dear Santa' holiday giveaway campaign, inviting people affected by hyperhidrosis to write letters explaining why they want to win a Dermadry iontophoresis device. One selected participant will receive a Dermadry Total machine valued at $499, with submissions closing on December 14, 2020. The company states the initiative aims to raise awareness of hyperhidrosis and bring holiday cheer during the COVID-19 pandemic.PR NewswireDermadry Celebrates Hyperhidrosis Month With New Awareness InitiativesDermadry, a Montreal-based company, announced the launch of Hyperhidrosis Awareness Month initiatives in November 2020, collaborating with the International Hyperhidrosis Society to raise awareness about the medical condition affecting approximately 5% of the global population.PR NewswireA Sweat-Free School Year: Dermadry Launches 2020 Scholarship For Students Who Sweat Too MuchDermadry, a Canadian medical device company, has launched the second edition of its annual scholarship contest for students suffering from hyperhidrosis, a condition causing excessive sweating that affects approximately 5% of the global population. Students are required to submit video entries discussing how the condition impacts their studies and daily life, with submissions open globally from August 3-19, 2020. The prize includes a US$2,000 scholarship and a Dermadry Total device valued at US$499, with ten finalists to be selected by Dermadry and the winner determined by public vote.